The following represents disclosure information provided by authors of this abstract. The Gastrointestinal Cancers Symposium Program Committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered self-held and compensated unless otherwise noted. Employment/Leadership relationships are considered compensated employment unless otherwise noted. L = Leadership, U = Uncompensated, I = Immediate Family Member, B = Both Myself and Immediate Family Member, Inst = My Institution
Retrospective cohort study on the safety and efficacy of cetuximab for metastatic colorectal cancer patients: HGCSG0901—Analysis of predictive markers.
Kazuteru Hatanaka
No relevant relationships to disclose
Satoshi Yuki
No relevant relationships to disclose
Hiroshi Nakatsumi
No relevant relationships to disclose
Takahiro Kogawa
No relevant relationships to disclose
Hiraku Fukushima
No relevant relationships to disclose
Koshi Fujikawa
No relevant relationships to disclose
Yasushi Sato
No relevant relationships to disclose
Mayuko Saito
No relevant relationships to disclose
Masaki Munakata
No relevant relationships to disclose
Yoshito Komatsu
No relevant relationships to disclose